1. Home
  2. CGEM
  3. CGEM News

Latest Cullinan Oncology Inc. (CGEM) News on December 24, 2024

Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus

GlobeNewswire

2 months ago

Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus

Associated Press Finance

a year ago

City Holding: Q4 Earnings Snapshot

Share on Social Networks: